Dolutegravir as First- or Second-line Treatment for Children With HIV: 240-Week Follow-up of the ODYSSEY Randomized Trial.
Saved in:
| Title: | Dolutegravir as First- or Second-line Treatment for Children With HIV: 240-Week Follow-up of the ODYSSEY Randomized Trial. |
|---|---|
| Authors: | Mujuru, Hilda Angela1 (AUTHOR), White, Ellen2 (AUTHOR), Kekitiinwa, Adeodata R3 (AUTHOR), Lugemwa, Abbas4 (AUTHOR), Kityo, Cissy5 (AUTHOR), Violari, Avy6 (AUTHOR), Ahimbisibwe, Grace Miriam7 (AUTHOR), Variava, Ebrahim6 (AUTHOR), Archary, Moherndran8 (AUTHOR), Cotton, Mark9 (AUTHOR) |
| Source: | Open Forum Infectious Diseases. May2026, Vol. 13 Issue 5, p1-9. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
